ABATACEPT TREATMENT OF PATIENTS WITH EARLY ACTIVE PRIMARY SJOGREN'S SYNDROME - A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III-STUDY (ASAP-III)

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)93-93
Number of pages1
JournalAnnals of the Rheumatic Diseases
Volume78
DOIs
Publication statusPublished - Jun-2019
EventAnnual European Congress of Rheumatology (EULAR) - Madrid, Spain
Duration: 12-Jun-201915-Jun-2019

Cite this